促进COVID-19疫苗接受度:美国柳叶刀疫苗拒绝、接受与需求委员会的推荐
自2020年1月美国发现首例COVID-19病例以来,美国已有超过4600万人SARS-CoV-2检测阳性。多种COVID-19疫苗获得美国食品药品监督管理局紧急使用授权,辉瑞-BioNTech疫苗于2021年8月23日获得完全批准。与戴口罩、保持身体距离和通风相结合,COVID-19疫苗是持续控制大流行的最佳干预措施。然而调查一致发现,相当一部分美国居民不计划接种COVID-19疫苗。疫苗摄取不足最严重的后果是持续的社区传播(包括delta[B.1.617.2]变异株,其激增始于2021年7月)。
要点
- 美国已有超过4600万人SARS-CoV-2检测阳性(自2020年1月首例以来)。
- 辉瑞-BioNTech疫苗于2021年8月23日获得美国食品药品监督管理局完全批准。
- 疫苗与戴口罩、保持身体距离和通风相结合,是持续控制大流行的最佳干预措施。
- 调查一致发现相当一部分美国居民不计划接种COVID-19疫苗。
- 疫苗摄取不足导致持续社区传播,包括delta(B.1.617.2)变异株(2021年7月开始激增)。
适用人群与场景
- 美国居民,尤其是低收入的少数族裔群体。
研究设计与关键结果
- 委员会通过一系列推荐,提出协调的、基于证据的教育、沟通和行为干预策略,该策略可能改善美国COVID-19疫苗接种计划的成功率。
- 疫苗摄取不足将延长大流行对家庭和社区的社会和经济影响,尤其是低收入的少数族裔群体,延续到2022年甚至更久。
证据类型、等级与局限
- 指南:美国柳叶刀疫苗拒绝、接受与需求委员会推荐。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出具体临床推荐。
指南或共识出处
- 美国柳叶刀疫苗拒绝、接受与需求委员会推荐,发表于Lancet。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Since the first case of COVID-19 was identified in the USA in January, 2020, over 46 million people in the country have tested positive for SARS-CoV-2 infection. Several COVID-19 vaccines have received emergency use authorisations from the US Food and Drug Administration, with the Pfizer-BioNTech vaccine receiving full approval on Aug 23, 2021. When paired with masking, physical distancing, and ventilation, COVID-19 vaccines are the best intervention to sustainably control the pandemic. However, surveys have consistently found that a sizeable minority of US residents do not plan to get a COVID-19 vaccine. The most severe consequence of an inadequate uptake of COVID-19 vaccines has been sustained community transmission (including of the delta [B.1.617.2] variant, a surge of which began in July, 2021). Exacerbating the direct impact of the virus, a low uptake of COVID-19 vaccines will prolong the social and economic repercussions of the pandemic on families and communities, especially low-income and minority ethnic groups, into 2022, or even longer. The scale and challenges of the COVID-19 vaccination campaign are unprecedented. Therefore, through a series of recommendations, we present a coordinated, evidence-based education, communication, and behavioural intervention strategy that is likely to improve the success of COVID-19 vaccine programmes across the USA.
参考来源
- Omer SB, Benjamin RM, Brewer NT, et al. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. Lancet. 2021. PMID: 34793741. doi:10.1016/S0140-6736(21)02507-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。